Want to see SG:A50 full AI Analyst Report?
A50 Stock Chart & Stats
S$0.06
S$0.00(0.00%)
At close: 4:00 PM EST
S$0.06
S$0.00(0.00%)
Day’s Range― - ―
52-Week RangeS$0.05 - S$0.07
Previous CloseN/A
Volume460.80K
Average Volume (3M)886.57K
Market Cap
S$1.24B
Enterprise ValueS$2.47B
Total Cash (Recent Filing)S$105.11M
Total Debt (Recent Filing)S$1.13B
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.73%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding26,443,615,000
10 Day Avg. Volume951,270
30 Day Avg. Volume886,573
Financial Highlights & Ratios
PEG Ratio1.22
Price to Book (P/B)3.11
Price to Sales (P/S)3.27
P/FCF Ratio26.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
S$0.07Price Target Upside16.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)S$455.90M
Bulls Say, Bears Say
Bulls Say
Positive Cash GenerationConsistently positive operating cash flow and a FY2026 improvement in free cash flow provide internal funding capacity despite reported losses. This supports ongoing operations and investment while reducing immediate reliance on external financing, although sustainability still requires monitoring.
Established Healthcare PlatformA defined focus on hospital and specialist clinical care gives Thomson Medical a clear operating platform within private healthcare services. This established business scope can support continuity across the medium term, provided financial performance and leverage are brought under control.
History Of Revenue ExpansionThe multi-year record includes strong revenue growth in FY2022 and FY2023 and a rebound in FY2025, demonstrating that the business has previously expanded its top line. That history provides a foundation for recovery if the recent FY2026 contraction proves reversible.
Bears Say
Recent Revenue ContractionThe sharp FY2026 revenue decline interrupts the prior growth and rebound pattern, weakening visibility into the company’s near-term earnings base. Continued contraction would reduce operating leverage and make it harder for the healthcare platform to absorb fixed costs.
Persistent LossesThe shift from several years of profit to losses in FY2025 and FY2026 indicates a material deterioration in earnings quality. Sustained losses could constrain reinvestment and weaken financial resilience, even though operating and free cash flow remain positive.
Elevated LeverageRising debt relative to shareholders’ capital has reduced balance-sheet flexibility while the company is loss-making. Elevated leverage can limit management’s ability to fund expansion internally, absorb further earnings weakness, or allocate capital to strengthen the business.
Thomson Medical Group Ltd. News
A50 FAQ
What was Thomson Medical Group Ltd.’s price range in the past 12 months?
Thomson Medical Group Ltd. lowest share price was S$0.05 and its highest was S$0.07 in the past 12 months.
What is Thomson Medical Group Ltd.’s market cap?
Thomson Medical Group Ltd.’s market cap is S$1.24B.
When is Thomson Medical Group Ltd.’s upcoming earnings report date?
Thomson Medical Group Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 20 days.
How were Thomson Medical Group Ltd.’s earnings last quarter?
Thomson Medical Group Ltd. released its earnings results on Aug 26, 2026. The company reported -S$0.001 earnings per share for the quarter, missing the consensus estimate of S$0 by -S$0.001.
Is Thomson Medical Group Ltd. overvalued?
According to Wall Street analysts Thomson Medical Group Ltd.’s price is currently Undervalued.
Does Thomson Medical Group Ltd. pay dividends?
Thomson Medical Group Ltd. pays a Annually dividend of <S$0.001 which represents an annual dividend yield of 0.73%. See more information on Thomson Medical Group Ltd. dividends here
What is Thomson Medical Group Ltd.’s EPS estimate?
Thomson Medical Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Thomson Medical Group Ltd. have?
Thomson Medical Group Ltd. has 26,443,615,000 shares outstanding.
What happened to Thomson Medical Group Ltd.’s price movement after its last earnings report?
Thomson Medical Group Ltd. reported an EPS of -S$0.001 in its last earnings report, missing expectations of S$0. Following the earnings report the stock price went up 1.887%.
Which hedge fund is a major shareholder of Thomson Medical Group Ltd.?
Currently, no hedge funds are holding shares in SG:A50
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Thomson Medical Group Ltd.
Operating as an investment holding company, Thomson Medical Group Limited delivers healthcare services specifically tailored for women and children across Singapore, Malaysia, and Vietnam. Its core assets include the Thomson Medical Centre, alongside an extensive network of affiliated medical clinics and healthcare facilities. The group's service portfolio encompasses immediate care solutions, covering basic resuscitation, ECG, vaccinations, intravenous fluid and antibiotic treatments, minor surgeries and procedures, wound management, and essential diagnostic imaging like X-rays and laboratory tests. Additionally, it provides comprehensive health screening, aesthetic and dermatological services, pain and rehabilitation management, and traditional herbal tea offerings. Furthermore, Thomson Medical Group specializes in a broad spectrum of medical areas. These include women's and children's health, fertility and family planning, ophthalmology, general surgery, urology, preventive health, healthy aging, advanced diagnostic imaging, breast care, cardiology, respiratory and critical care, endocrinology, dermatology, day surgery, general surgical care, counselling, therapy, Traditional Chinese Medicine (TCM), and specialized care for bone, joint, gynecological oncology, dental, and spine conditions. The company's diverse range of products and services are marketed under well-known brands such as Thomson Women's Clinic, Thomson Fertility Centre, Thomson Paediatric Clinic, Thomson Specialists, Thomson Chinese Medicine, Thomson Surgical Centre, Thomson Dental Centre, Thomson Hospital Kota Damansara, TMC Fertility, TMC Care Pharmacy, FV Hospital, and FV Saigon Clinic. Established in 1979, Thomson Medical Group Limited is headquartered in Singapore.
A50 Stock 12 Month Forecast
Average Price Target
S$0.07
▲(16.67% Upside)
Technical Analysis
Cordlife Group
―
Raffles Medical Group
―
Asiamedic Limited
―
OUE Lippo Healthcare Limited
―
Bangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 Sh
―